Swiss rare disease registry for patients and caregivers
This study builds a “registry,” which is a secure list of people with rare diseases or suspected rare diseases in Switzerland. It helps researchers better understand these conditions over time and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosed rare disease, or a high suspicion of one
- You currently live in Switzerland, or you receive treatment in Switzerland
- You agree to take part by signing informed consent
- There are no listed study exclusions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tries to find genetic causes for rare diseases that are not yet understood. It uses a national rare-disease data bank and collects consent from patients and sometimes close family members.
This study collects and stores samples and related medical information for people with rare diseases or suspected genetic conditions. It may help researchers better understand these conditions and develop future testing and treatments.
This registry enrolls people with a confirmed diagnosis of multiple sclerosis (MS) who are age 18 or older and live in Switzerland (or receive their MS care there). It helps researchers better understand MS in the Swiss population and may improve future studies and care.
This study is a patient registry that collects health information from people diagnosed with a neuromuscular disorder in Switzerland. It helps researchers better understand these conditions and how they vary from person to person.
This study keeps a registry (a secure list) of adults with diabetes. It collects information over time to better understand diabetes and support care—your participation is voluntary.
This registry study collects information about people with cerebral palsy in Switzerland. It helps researchers better understand CP and related needs over time, which can support future care and studies.
Hear when a new Rare Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.